AST SpaceMobile Down 33% as Launch Delays Pressure High-Flying Stock

What happened

AST SpaceMobile (ASTS) has fallen 33% from its 52-week high, driven by delays in its 2026 launch plans tied to issues with Blue Origin's New Glenn rocket, as reported by The Motley Fool. The stock's decline reflects market disappointment that the critical mid-June launch of BlueBird 8-10 may slip, threatening the cadence needed to transition from a pre-revenue development stage to operational service. According to the DeepValue report, the company's $54.2 billion market cap at $113.40 per share hinges on launching BB8–BB10 on time and commissioning them by Q3 2026, while also securing insurance recovery for the lost BlueBird 7 satellite (a ~$155-160M write-off). Without these milestones, the stock remains overvalued relative to its $14.7 million quarterly revenue base and $191 million quarterly net loss. The current price drop may be pricing in bear-case probabilities, but the next definitive catalyst—the actual launch and Q2'26 insurance disclosure—remains binary.

Implication

While the pullback may provide an attractive entry, the catalyst-dependent nature of ASTS means investors should only accumulate after confirmation of launch timing and insurance recovery for BB7. Until then, the stock's risk/reward is skewed to the downside given its lofty valuation and lack of service revenue.

Thesis delta

The DeepValue thesis remains unchanged at WAIT, but the price decline increases the margin of safety towards the $85 attractive entry level. The key risk of launch delays is now partially reflected, but the core investment case still requires BB8-10 launch and BB7 insurance resolution. No shift in rating until these proof points emerge.